Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuli Mao

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|November 29, 2017
Simple <i>In Vitro</i> Assay To Evaluate the Incorporation Efficiency of Ribonucleotide Analog 5'-Triphosphates into RNA by Human Mitochondrial DNA-Dependent RNA PolymeraseGaofei Lu, Gregory R Bluemling, Shuli Mao, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Pharmacology and pharmacokinetics of the antiviral agent beta-D-2',3'-dideoxy-3'-oxa-5-fluorocytidine in cells and rhesus monkeysBrenda I Hernandez-Santiago, Huachun Chen, Ghazia Asif, et al.
Mbio|September 12, 2025
Effective treatment of advanced Oropouche virus, Rift Valley fever virus, and Dabie bandavirus infections with 4'-fluorouridineJonna B Westover, Kie Hoon Jung, Inioska Rojas, et al.
Antiviral Research|November 15, 2022
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N<sup>4</sup>-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infectionGregory R Bluemling, Shuli Mao, Michael G Natchus, et al.
Journal of Medicinal Chemistry|March 1, 2017
Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase ComplexAlberto Jiménez-Somarribas, Shuli Mao, Jeong-Joong Yoon, et al.
Journal of Virology|March 21, 2024
Modeling Heartland virus disease in mice and therapeutic intervention with 4'-fluorouridineJonna B Westover, Kie Hoon Jung, Cigdem Alkan, et al.
European Journal of Medicinal Chemistry|February 25, 2026
Development of a nucleotide prodrug of 4'-fluorouridine to improve tolerabilityAustin T Ryan, Jean-Marc I A Lawrence, Brett Virgin-Downey, et al.
Science Translational Medicine|November 20, 2024
Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal diseaseStephen R Welch, Jessica R Spengler, Jonna B Westover, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|November 29, 2017
Simple <i>In Vitro</i> Assay To Evaluate the Incorporation Efficiency of Ribonucleotide Analog 5'-Triphosphates into RNA by Human Mitochondrial DNA-Dependent RNA PolymeraseGaofei Lu, Gregory R Bluemling, Shuli Mao, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Pharmacology and pharmacokinetics of the antiviral agent beta-D-2',3'-dideoxy-3'-oxa-5-fluorocytidine in cells and rhesus monkeysBrenda I Hernandez-Santiago, Huachun Chen, Ghazia Asif, et al.
Mbio|September 12, 2025
Effective treatment of advanced Oropouche virus, Rift Valley fever virus, and Dabie bandavirus infections with 4'-fluorouridineJonna B Westover, Kie Hoon Jung, Inioska Rojas, et al.
Antiviral Research|November 15, 2022
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N<sup>4</sup>-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infectionGregory R Bluemling, Shuli Mao, Michael G Natchus, et al.
Journal of Medicinal Chemistry|March 1, 2017
Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase ComplexAlberto Jiménez-Somarribas, Shuli Mao, Jeong-Joong Yoon, et al.
Journal of Virology|March 21, 2024
Modeling Heartland virus disease in mice and therapeutic intervention with 4'-fluorouridineJonna B Westover, Kie Hoon Jung, Cigdem Alkan, et al.
European Journal of Medicinal Chemistry|February 25, 2026
Development of a nucleotide prodrug of 4'-fluorouridine to improve tolerabilityAustin T Ryan, Jean-Marc I A Lawrence, Brett Virgin-Downey, et al.
Science Translational Medicine|November 20, 2024
Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal diseaseStephen R Welch, Jessica R Spengler, Jonna B Westover, et al.
Pageof 2